US Patent 7491397 Receptor binding polypeptides

Patent 7491397 was granted and assigned to National Health Research Institutes on February, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 10 Apr, 2024

"update inverses"

Golden AI

edited on 10 Apr, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11951174 Therapeutics directed against coronavirus

Edits on 17 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 17 Sep, 2023

Edits made to:

Infobox (+2 properties)

Infobox

Patent Inventor Names

Pele Choi Sing Chong0

Shie-Liang Hsieh0

Edits on 15 Sep, 2023

"Add patent abstract"

Golden AI

edited on 15 Sep, 2023

Edits made to:

Article (+451 characters)

Article

Patent abstract

Isolated polypeptides containing fragments of SARS CoV S protein and functional equivalents thereof. Also disclosed are isolated nucleic acids encoding the polypeptides, related expression vectors, related host cells, related antibodies, and related compositions. Methods of producing the polypeptide, diagnosing infection with a coronavirus, and identifying a test compound for treating infection with a coronavirus are also disclosed.

Edits on 22 Jul, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 22 Jul, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=074913970

Edits on 25 May, 2023

"Remove leading 0 from patent number"

Golden AI